Acute toxicities of saxitoxin, neosaxitoxin, decarbamoyl saxitoxin and gonyautoxins 1&4 and 2&3 to mice by various routes of administration

Toxicon

Volumn 76, Issue , 2013, Pages 77-83

  Munday, Rex ^a   Thomas, Krista ^b   Gibbs, Ryan ^c   Murphy, Cory ^c   Quilliam, Michael A ^b  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

Acute toxicity; Decarbamoyl saxitoxin; Gonyautoxins; Neosaxitoxin; Saxitoxin; Toxicity equivalence factors

Indexed keywords

DECARBAMOYLSAXITOXIN; GONYAUTOXIN; NEOSAXITOXIN; SAXITOXIN;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; FEMALE; LD 50; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICITY EQUIVALENCE FACTOR; TOXICOLOGICAL PARAMETERS;

MUS;

ACUTE TOXICITY; DECARBAMOYL SAXITOXIN; GONYAUTOXINS; NEOSAXITOXIN; SAXITOXIN; TOXICITY EQUIVALENCE FACTORS;

ADMINISTRATION, ORAL; ANIMALS; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; MARINE TOXINS; MICE; SAXITOXIN;

EID: 84885044797     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.09.013     Document Type: Article

References (30)

1. Anderson D.M., Alpermann T.J., Cembella A.D., Collos Y., Masseret E., Montresor M. The globally distributed genus Alexandrium: multifaceted roles in marine ecosystems and impacts on human health. Harmful Algae 2012, 14:10-35.
2. AOAC Official method 959.08. Paralytic shellfish poison. Biological method. Official Methods of Analysis of AOAC International 2005, 79-82. AOAC International, Gaithersburg. 18th ed. W. Horwitz, G.W. Latimer (Eds.).
3. Davio S.R. Neutralization of saxitoxin by anti-saxitoxin rabbit serum. Toxicon 1985, 23:669-675.
4. Dell'Aversano C., Hess P., Quilliam M.A. Hydrophilic interaction liquid chromatography-mass spectrometry for the analysis of paralytic shellfish poisoning (PSP) toxins. J. Chromatogr. A 2005, 1081:190-201.
5. EFSA EFSA Panel on Contaminants in the Food Chain. Marine biotoxins in shellfish - saxitoxin group. EFSA J. 2009, 1019. 76 pp.
6. Etheridge S.M. Paralytic shellfish poisoning: seafood safety and human health perspectives. Toxicon 2010, 56:108-122.
7. Evans M.H. Two toxins from a poisonous sample of mussels Mytilus edulis. Br. J. Pharmacol. 1970, 40:847-865.
8. FAO Marine Biotoxins 2004, Food and Agriculture Organisation of the United Nations Food and Nutrition, Paper 80.
9. García C., del Carmen Bravo M., Lagos M., Lagos N. Paralytic shellfish poisoning: post-mortem analysis of tissue and body fluid samples from human victims in the Patagonia fjords. Toxicon 2004, 43:149-158.
10. Ghazarossian V.E., Schantz E.J., Schnoes H.K., Strong F.M. A biologically active acid hydrolysis product of saxitoxin. Biochem. Biophys. Res. Comm. 1976, 68:776-780.
11. Harada T., Oshima Y., Yasumoto T. Assessment of potential activation of gonyautoxin V in the stomach of mice and rats. Toxicon 1984, 22:476-478.
12. Laycock M.V., Thibault P., Ayer S.W., Walter J.A. Isolation and purification procedures for the preparation of paralytic shellfish poisoning toxin standards. Nat. Toxins 1994, 2:175-183.
13. McFarren E.F. Report on collaborative studies of the bioassay for paralytic shellfish poison. J. Ass. Off. Anal. Chem. Int. 1959, 72:263-271.
14. + channels by guanidinium toxins. Effect of toxin charge. J. Gen. Physiol. 1984, 84:687-704.
15. OECD Guidelines for the Testing of Chemicals 2008, Guideline 425. Acute Oral Toxicity - Up-and-Down Procedure.
16. Oshima Y. Postcolumn derivatization liquid chromatographic method for paralytic shellfish toxins. J. Ass. Off. Anal. Chem. Int. 1995, 78:528-532.
17. Pearson L., Mihali T., Moffitt M., Kellmann R., Neilan B. On the chemistry, toxicology and genetics of the cyanobacterial toxins, microcystin, nodularin, saxitoxin and cylindrospermopsin. Mar. Drugs 2010, 8:1650-1680.
18. Perez S., Vale C., Botana A.M., Alonso W., Vieytes M.R., Botana L.M. Determination of toxicity equivalent factors for paralytic shellfish toxins by electrophysiological measurements in cultured neurons. Chem. Res. Toxicol. 2011, 24:1153-1157.
19. Rossini G.P., Hess P. Phycotoxins: chemistry, mechanisms of action and shellfish poisoning. Molecular, Clinical and Environmental Toxicology 2010, 65-122. Birkhäuser, Basel. A. Luch (Ed.).
20. Schantz E.J., McFarren E.F., Schafer M.L., Lewis K.H. Purified shellfish poison for bioassay standardization. J. Ass. Off. Anal. Chem. 1958, 41:160-168.
21. Sommer H., Meyer K.F. Paralytic shell-fish poisoning. Arch. Pathol. 1937, 24:560-598.
22. Strichartz G. Structural determinants of the affinity of saxitoxin for neural sodium channels. Electrophysiological studies on frog peripheral nerve. J. Gen. Physiol. 1984, 84:281-305.
23. Sullivan J.J., Wekell M.M., Kentala L.L. Application of HPLC for the determination of PSP toxins in shellfish. J. Food Sci. 1985, 50:26-29.
24. Thibault P., Pleasance S., Laycock M.V. Analysis of paralytic shellfish poisons by capillary electrophoresis. J. Chromatogr. A 1991, 542:483-501.
25. USEPA User Documentation for the AOT425StatPgm Program 2002, http://www.oecd.org/dataoecd/19/57/1839830.pdf.
26. Usup G., Leaw C.-P., Cheah M.-Y., Ahmad A., Ng B.-K. Analysis of paralytic shellfish poisoning congeners by a sodium channel receptor binding assay. Toxicon 2004, 44:37-44.
27. Vale C., Alfonso A., Vieytes M.R., Romarís X.M., Arévalo F., Botana A.M., Botana L.M. Invitro and invivo evaluation of paralytic shellfish poisoning toxin potency and the influence of the pH of extraction. Anal. Chem. 2008, 80:1770-1776.
28. Van de Riet J.M., Gibbs R.S., Chou F., Muggah P.M., Rourke W.A., Burns G., Thomas K., Quilliam M.A. Liquid chromatographic post-column oxidation method for analysis of paralytic shellfish toxins in mussels, clams, scallops and oysters: single-laboratory validation. J. Ass. Off. Anal. Chem. Int. 2010, 92:1690-1704.
29. Wiberg G.S., Stephenson N.R. Toxicologic studies on paralytic shellfish poison. Toxicol. Appl. Pharmacol. 1960, 2:607-615.
30. Wiese M., D'Agostino P.M., Mihali T.K., Moffitt M.C., Neilan B.A. Neurotoxic alkaloids: saxitoxin and its analogs. Mar. Drugs 2010, 8:2185-2211.